PRIMARY CENTRAL NERVOUS SYSTEM TUMOR
Clinical trials for PRIMARY CENTRAL NERVOUS SYSTEM TUMOR explained in plain language.
Never miss a new study
Get alerted when new PRIMARY CENTRAL NERVOUS SYSTEM TUMOR trials appear
Sign up with your email to follow new studies for PRIMARY CENTRAL NERVOUS SYSTEM TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New oral drug shows promise for kids with rare RET-Driven cancers
Disease control OngoingThis study tests an oral drug called selpercatinib (LOXO-292) in children with advanced solid or brain tumors that have a specific RET gene change. The trial has two parts: first finding a safe dose, then measuring how many children's tumors shrink. About 36 children whose cancer…
Matched conditions: PRIMARY CENTRAL NERVOUS SYSTEM TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Brain radiation shield: Alzheimer's drug tested in kids with cancer
Symptom relief OngoingThis study tests whether memantine, a drug used for Alzheimer's, can protect memory and thinking in children aged 4-17 receiving brain radiation for central nervous system tumors. About 192 participants will receive either memantine or a placebo during and after radiation. The go…
Matched conditions: PRIMARY CENTRAL NERVOUS SYSTEM TUMOR
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC